1,313
Views
5
CrossRef citations to date
0
Altmetric
Research Article

5-Flurouracil microencapsulation and impregnation in hyaluronic acid hydrogel as composite drug delivery system for ocular fibrosis

, , , & | (Reviewing Editor)
Article: 1182108 | Received 28 Feb 2016, Accepted 20 Apr 2016, Published online: 18 May 2016

References

  • Arias, J. L. (2008). Novel strategies to improve the anticancer action of 5-Fluorouracil by using drug delivery systems. Molecules, 13, 2340–2369.10.3390/molecules13102340
  • Bae, J. W., Go, D. H., Park, K. D., & Lee, S. J. (2006). Thermosensitive chitosan as an injectable carrier for local drug delivery. Macromolecular Research, 14, 461–465.10.1007/BF03219111
  • Caicco, M. J., Cooke, M. J., Wang, Y., Tuladhar, A., Morshead, C. M., & Shoichet, M. S. (2013). A hydrogel composite system for sustained epi-cortical delivery of cyclosporin a to the brain for treatment of stroke. Journal of Controlled Release, 166, 197–202.10.1016/j.jconrel.2013.01.002
  • Chang, E., McClellan, A. J., Farley, W. J., Li, D. Q., Pflugfelder, S. C., & de Paiva, C. S. (2011). Biodegradable PLGA-based drug delivery systems for modulating ocular surface disease under experimental murine dry eye. Journal of Clinical & Experimental Ophthalmology, 2, 191–196.
  • Chiang, C. H., Tung, S. H., Lu, D. W., & Yeh, M. K. (2001). In vitro and in vivo evaluation of an ocular delivery system of 5-Fluorouracil microspheres. Journal of Ocular Pharmacology and Therapeutics, 17, 545–553.10.1089/10807680152729239
  • Choi, J. S., Seo, K., & Yoo, J. W. (2012). Recent advances in PLGA particulate systems for drug delivery. Journal of Pharmaceutical Investigation, 42, 155–163.10.1007/s40005-012-0024-5
  • Cook, C., & Foster, P. (2012). Epidemiology of glaucoma: What’s new? Canadian Journal of Ophthalmology, 47, 223–226.10.1016/j.jcjo.2012.02.003
  • Cui, L., Sun, N., Li, X., Huang, J., & Yang, J. (2008). Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery. Acta Pharmacologica Sinica, 29, 1021–1028.10.1111/aphs.2008.29.issue-9
  • Faisant, N., Siepmann, J., & Benoit, J. P. (2002). PLGA-based microparticles: Elucidation of mechanisms and a new, simple mathematical model quantifying drug release. European Journal of Pharmaceutical Sciences, 15, 355–366.10.1016/S0928-0987(02)00023-4
  • Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011). The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems–A review. International Journal of Pharmaceutics, 415, 34–52.10.1016/j.ijpharm.2011.05.049
  • Galeska, I., Kim, T. K., Patil, S. D., Bhardwaj, U., Chatttopadhyay, D., Papadimitrakopoulos, F., & Burgess, D. J. (2005). Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. The AAPS Journal, 7, E231–E240.10.1208/aapsj070122
  • Gooch, N., Molokhia, S. A., Condie, R., Burr, R. M., Archer, B., Ambati, B. K., & Wirostko, B. (2012). Ocular drug delivery for glaucoma management. Pharmaceutics, 4, 197–211.10.3390/pharmaceutics4010197
  • Green, E., Wilkins, M., Bunce, C., & Wormald, R. (2014). 5-Fluorouracil for glaucoma surgery. The Cochrane Database of Systematic Reviews,(2), 1–62. doi:10.1002/14651858.CD001132.pub2
  • Hoare, T. R., & Kohane, D. S. (2008). Hydrogels in drug delivery: Progress and challenges. Polymer, 49, 1993–2007.10.1016/j.polymer.2008.01.027
  • Hou, Q., Chau, D. Y., Pratoomsoot, C., Tighe, P. J., Dua, H. S., Shakesheff, K. M., & Rose, F. R. (2008). In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. Journal of Pharmaceutical Sciences, 97, 3972–3980.10.1002/jps.21310
  • How, A., Chua, J. L. L., Charlton, A., Su, R., Lim, M., Kumar, R. S., … Wong, T. T. (2010). Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery. Investigative Ophthalmology & Visual Science, 51, 928–932.
  • Howard, D., Buttery, L. D., Shakesheff, K. M., & Roberts, S. J. (2008). Tissue engineering: Strategies, stem cells and scaffolds. Journal of Anatomy, 213, 66–72.10.1111/joa.2008.213.issue-1
  • Huhtala, A. R. S., Rönkkö, S., Teräsvirta, M., Puustjärvi, T., Sihvola, R., Vehanen, K., … Uusitalo, H. (2009). The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant. Investigative Opthalmology & Visual Science, 50, 2216–2223.10.1167/iovs.08-3016
  • Jacob, J. T., LaCour, O. J., & Burgoyne, C. F. (2001). Slow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain function. Biomaterials, 22, 3329–3335.10.1016/S0142-9612(01)00170-3
  • Jin, Y. J., Ubonvan, T., & Kim, D. D. (2010). Hyaluronic acid in drug delivery systems. Journal of Pharmaceutical Investigation, 40, 33–43.10.4333/KPS.2010.40.S.033
  • Joung, Y. K., Choi, J. H., Park, K. M., & Park, K. D. (2007). PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs. Biomedical Materials, 2, 269–273.10.1088/1748-6041/2/4/010
  • Ju, R., Wen, Y., Gou, R., Wang, Y., & Xu, Q. (2014). The experimental therapy on brain ischemia by improvement of local angiogenesis with tissue engineering in the mouse. Cell Transplantation, 23, S83–S95.10.3727/096368914X684998
  • Kimura, H., & Ogura, Y. (2001). Biodegradable polymers for ocular drug delivery. Ophthalmologica, 215, 143–155.10.1159/000050849
  • Kingman, S. (2004). Glaucoma is second leading cause of blindness globally. Bulletin of the World Health Organization, 82, 887–888.
  • Kogan, G., Soltes, L., Stern, R., & Gemeiner, P. (2007). Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnology Letters, 29, 17–25.
  • Kondo, M., & Aroie, M. (1989). Iontophoresis of 5-fluorourocil into the conjunctiva ond sclero. Investigative Ophthalmology & Visual Science, 30, 583–585.
  • Kozobolis, V., Konstantinidis, A., & Labiris, G. (2013). Combined cataract-glaucoma surgery. In: S. Rumelt (Ed.) Glaucoma–basic and clinical aspects.(pp. 473–510). Israel: InTech.
  • Lagarce, F., Faisant, N., Desfontis, J. C., Marescaux, L., Gautier, F., Richard, j., … Benoit, J. P. (2005). Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: In vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 61, 171–180.10.1016/j.ejpb.2005.04.004
  • Lee, D. A., Hersh, P., Kersten, D., & Melamed, S. (1987). Complications of subconjunctival 5-fluorouracil following glaucoma filtering surgery. Ophthalmic Surgery, 18, 187–190.
  • Lin, Y., Sun, J., Jiang, G., Zan, J., & Ding, F. (2007). In vitro evaluation of lysozyme-loaded microspheres in methylcellulose hydrogel. Chinese Journal of Chemical Engineering, 15, 566–572.10.1016/S1004-9541(07)60125-6
  • Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-Fluorouracil: Mechanisms of action and clinical strategies. Nature Reviews Cancer, 3, 330–338.10.1038/nrc1074
  • Lu, D. W., Chang, C. J., Chiang, C. H., Yeh, M. K., & Chou, P. I. (2000). Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. Journal of Ocular Pharmacology and Therapeutics, 16, 529–538.10.1089/jop.2000.16.529
  • Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003). Tumor acidity, ion trapping and chemotherapeutics I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochemical Pharmacology, 66, 1207–1218.10.1016/S0006-2952(03)00467-2
  • Makadia, H. K., & Siegel, S. J. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 3, 1377–1397.10.3390/polym3031377
  • Mead, A. L., Wong, T. T. L., Cordeiro, M. F., Anderson, I. K., & Khaw, P. T. (2003). Evaluation of anti-TGF-2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Investigative Ophthalmology & Visual Science, 44, 3394–3401.
  • Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S. H., & Ikada, Y. (1991). Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. Investigative Ophthalmology & Visual Science, 32, 1785–1790.
  • Mufamadi, M. S., Pillay, V., Choonara, Y. E., Du Toit, L. C., Modi, G., Naidoo, D., & Ndesendo, V. M. (2011). A review on composite liposomal technologies for specialized drug delivery. Journal of Drug Delivery, 2011, 1–19.10.1155/2011/939851
  • Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Journal of Controlled Release, 125, 193–209.10.1016/j.jconrel.2007.09.013
  • Naguib, Y. W., Kumar, A., & Cui, Z. (2014). The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil. Acta Pharmaceutica Sinica B, 4, 94–99.10.1016/j.apsb.2013.12.013
  • Nasr, M., Ghorab, M. K., & Abdelazem, A. (2015). In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharmaceutica Sinica B, 5, 79–88.10.1016/j.apsb.2014.12.001
  • Nath, S. D., Linh, N. T., Sadiasa, A., & Lee, B. T. (2014). Encapsulation of simvastatin in PLGA microspheres loaded into hydrogel loaded BCP porous spongy scaffold as a controlled drug delivery system for bone tissue regeneration. Journal of Biomaterials Applications, 28, 1151–1163.10.1177/0885328213499272
  • Nettles, D. L., Vail, T. P., Morgan, M. T., Grinstaff, M. W., & Setton, L. A. (2004). Photocrosslinkable hyaluronan as a scaffold for articular cartilage repair. Annals of Biomedical Engineering, 32, 391–397.10.1023/B:ABME.0000017552.65260.94
  • Patterson, J., Stayton, P. S., & Li, X. (2009). In situ characterization of the degradation of PLGA microspheres in hyaluronic acid hydrogels by optical coherence tomography. IEEE Transactions on Medical Imaging, 28, 74–81.10.1109/TMI.2008.927356
  • Perucho-Martínez, S., Gutiérrez-Díaz, E., Montero-Rodríguez, M., Mencía-Gutiérrez, E., & Lago-Llinás, M. D. (2006). Needle revision of late failing filtering blebs after glaucoma surgery. Archives of the Spanish Society of Ophthalmology, 81, 517–522.
  • Peyman, G. A., Conway, M., Khoobehi, B., & Soike, K. (1992). Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates. International Ophthalmology, 16, 109–113.10.1007/BF00918942
  • Quigley, H. A. (2011). Glaucoma. The Lancet, 377, 1367–1377.10.1016/S0140-6736(10)61423-7
  • Quigley, H. A., & Borman, A. T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology, 90, 262–267.10.1136/bjo.2005.081224
  • Ranganath, S. H., Kee, I., Krantz, W. B., Chow, P. K., & Wang, C. H. (2009). Hydrogel matrix entrapping PLGA-paclitaxel microspheres: Drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy. Pharmaceutical Research, 26, 2101–2114.10.1007/s11095-009-9922-2
  • Rocíoh, V. (2011). Microparticles as drug delivery systems for the back of the eye. In B. E. H. F. Kompellau (Ed.), Drug product development for the back of the eye (pp. 231–259). New York, NY: American Association of Pharmaceutical Scientists.
  • Samadi, N., Abbadessa, A., Di Stefano, A., van Nostrum, C. F., Vermonden, T., Rahimian, S., … Hennink, W. E. (2013). The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Journal of Controlled Release, 172, 436–443.10.1016/j.jconrel.2013.05.034
  • Shelke, N. B., Kadam, R., Tyagi, P., Rao, V. R., & Kompella, U. B. (2011). Intravitreal poly(L-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases. Drug Delivery and Translational Research, 1, 76–90.10.1007/s13346-010-0009-8
  • Siegelr, A., & Rathbonem, J. (2012). Overview of controlled release mechanisms. In J. Siepmann, A. Siegelr, & J. Rathbonem (Eds.), Fundamentals and applications of controlled release drug delivery, advances in delivery science and technology. (pp. 19–43). New York, NY: Springer.
  • Smeds, K. A., Pfister-Serres, A., Miki, D., Dastgheib, K., Inoue, M., Hatchell, D. L., & Grinstaff, M. W. (2000). Photocrosslinkable polysaccharides for in situ hydrogel formation. Journal of Biomedical Materials Research, 54, 115–121.
  • Tous, E., Weber, H. M., Lee, M. H., Koomalsingh, K. J., Shuto, T., Kondo, N., … Burdick, J. A. (2012). Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking. Acta Biomaterialia, 8, 3218–3227.10.1016/j.actbio.2012.05.027
  • Wang, G., Tucker, I. G., Roberts, M. S., & Hirst, L. W. (1996). In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Pharmaceutical Research, 13, 1059–1064.10.1023/A:1016062825360
  • Wang, Y., Wei, Y. T., Zu, Z. H., Ju, R. K., Guo, M. Y., Wang, X. M., … Cui, F. Z. (2011). Combination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells. Pharmaceutical Research, 28, 1406–1414.10.1007/s11095-011-0452-3
  • Widjaja, L. K., Bora, M., Chan, P. N., Lipik, V., Wong, T. T., & Venkatraman, S. S. (2014). Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications. Journal of Biomedical Materials Research Part A, 102, 3056–3065.10.1002/jbm.a.v102.9
  • Wormald, R., Wilkins, M., & Bunce, C. (2001). Post-operative 5-fluorouracil for glaucoma surgery. The Cochrane Database of Systematic Reviews,(3), 1–33. doi:10.1002/14651858.CD001132.pub2
  • Yeh, M. K., Tung, S. M., Lu, D. W., Chen, J. L., & Chiang, C. H. (2001). Formulation factors for preparing ocular biodegradable delivery system of 5-fuorouracil microparticles. Journal of Microencapsulation, 18, 507–519.
  • You, H., Lee, E. U., Kim, Y. K., Kim, B. C., Park, J. Y., Lim, H. C., … Choi, S. H. (2014). Biocompatibility and resorption pattern of newly developed hyaluronic acid hydrogel reinforced three-layer poly (lactide-co-glycolide) membrane: Histologic observation in rabbit calvarial defect model. Biomaterials Research, 18, 12–18.10.1186/2055-7124-18-12
  • Zhao, J., Guo, B., & Ma, P. X. (2014). Injectable alginate microsphere/PLGA–PEG–PLGA composite hydrogels for sustained drug release. RSC Advances, 4, 17736–17742.10.1039/c4ra00788c
  • Zimmer, A., & Kreuter, J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews, 16, 61–73.10.1016/0169-409X(95)00017-2